# Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers

> **NCT00656357** · PHASE1,PHASE2 · COMPLETED · sponsor: **Biotie Therapies Inc.** · enrollment: 20 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** SYN117 Placebo
- **DRUG:** SYN117 80 mg
- **DRUG:** SYN117 160 mg
- **DRUG:** Cocaine 10mg
- **DRUG:** Cocaine 20mg
- **DRUG:** Cocaine 40mg
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00656357
- **Lead sponsor:** Biotie Therapies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656357, "Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00656357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*